Drugs / IFALMIN®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07186478 | Dec 2024 → Oct 2025 overdue | hypoproteinemia, hypercatabolic, pulmonary tuberculosis | Hasanuddin University | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IFALMIN | “IFALMIN® is a standardized herbal preparation derived from Channa micropeltes (ikan toman), containing natural albumin.” NCT07186478 ↗ |
| Route | Oral | “Administered orally in capsule form” NCT07186478 ↗ |